Singapore markets close in 3 hours 33 minutes

Straits Times Index
3,322.56
+8.42(+0.25%)
Nikkei
39,095.49
+290.84(+0.75%)
Hang Seng
18,100.36
+72.65(+0.40%)
FTSE 100
8,281.55
+43.83(+0.53%)
Bitcoin USD
61,340.00
-1,158.62(-1.85%)
CMC Crypto 200
1,274.20
-35.51(-2.71%)

MRNA Mar 2025 170.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

17.35

0.00

(0.00%)

As of 12:23PM EDT. Market open.

Simply Wall St.
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
In the last year, many Moderna, Inc. ( NASDAQ:MRNA ) insiders sold a substantial stake in the company which may have...
Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
Zacks
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.